Old Web
English
Sign In
Acemap
>
authorDetail
>
Anson Pontynen
Anson Pontynen
Physical therapy
Medicine
Family medicine
Excellence
Cancer
5
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
VP22 Cancer Drugs Fund Allocation Under The National Institute for Health and Care Excellence (NICE): The First Six Months
2017
International Journal of Technology Assessment in Health Care
Daniel Liden
Anson Pontynen
Ashley Jaksa
Judith Rubinstein
Show All
Source
Cite
Save
Citations (0)
VP157 What Is The Response To Immuno-Oncology By Health Technology Assessment Agencies?
2017
International Journal of Technology Assessment in Health Care
Boaz Adler
Jake Blumenthal
Ruth Chang
S. Yin Ho
Ashley Jaksa
Briana Lurie
Anson Pontynen
E. Rubinstein
Rc Sliman
Judith Rubinstein
Show All
Source
Cite
Save
Citations (0)
Exploring the time delay between regulatory approval and health techonology assessments (HTAs) of oncology therapies in France, Germany, England, Scotland, Canada, and Australia.
2017
Journal of Clinical Oncology
Ashley Jaksa
Anson Pontynen
Alexander Bastian
Show All
Source
Cite
Save
Citations (3)
An exploration of how a countries' HTA process can affect patient access.
2017
Journal of Clinical Oncology
Ashley Jaksa
Anson Pontynen
Alexander Bastian
Show All
Source
Cite
Save
Citations (1)
OP03 Trends In The National Institute for Health and Care Excellence (NICE) Cancer Drugs Fund Reconsiderations
2017
International Journal of Technology Assessment in Health Care
Daniel Liden
Anson Pontynen
Ashley Jaksa
Judith Rubinstein
Show All
Source
Cite
Save
Citations (0)
1